Tandem Diabetes Care, Inc.
TNDM
$19.28
$1.106.05%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 755.00K | -23.25M | -30.81M | -42.72M | -30.00M |
Total Depreciation and Amortization | 4.25M | 4.21M | 4.11M | 4.04M | 4.03M |
Total Amortization of Deferred Charges | 502.00K | 502.00K | 435.00K | 650.00K | 493.00K |
Total Other Non-Cash Items | 28.53M | 30.19M | 29.49M | 25.12M | 26.58M |
Change in Net Operating Assets | -23.32M | 15.13M | -8.49M | 4.90M | -8.32M |
Cash from Operations | 10.72M | 26.78M | -5.28M | -8.00M | -7.22M |
Capital Expenditure | -3.07M | -5.24M | -6.47M | -4.46M | -5.20M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | 0.00 |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 8.08M | -14.66M | 2.93M | -599.00K | -11.39M |
Cash from Investing | 5.01M | -19.90M | -3.54M | -5.06M | -16.58M |
Total Debt Issued | -9.40M | 0.00 | 9.40M | 306.85M | -- |
Total Debt Repaid | 0.00 | 0.00 | 0.00 | -246.12M | -- |
Issuance of Common Stock | 2.30M | -- | -- | -- | 2.62M |
Repurchase of Common Stock | -- | -4.52M | -3.00M | -31.51M | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 9.40M | 0.00 | -9.40M | -15.63M | 0.00 |
Cash from Financing | 2.30M | -4.52M | -3.00M | 13.59M | 2.62M |
Foreign Exchange rate Adjustments | 2.17M | -1.02M | 535.00K | -423.00K | 440.00K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 20.20M | 1.34M | -11.28M | 111.00K | -20.74M |